% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @PHDTHESIS{Rahatianpur:958692, author = {Rahatianpur, Mehrdad}, othercontributors = {Rüffer, Andre and Brülls, Christian Simon}, title = {{T}he association of bicuspid aortic valve on long-term outcome following one-stage repair of aortic arch obstruction associated with ventricular septal defect}, school = {Rheinisch-Westfälische Technische Hochschule Aachen}, type = {Dissertation}, address = {Aachen}, publisher = {RWTH Aachen University}, reportid = {RWTH-2023-05385}, pages = {1 Online-Ressource : Illustrationen}, year = {2023}, note = {Veröffentlicht auf dem Publikationsserver der RWTH Aachen University; Dissertation, Rheinisch-Westfälische Technische Hochschule Aachen, 2023}, abstract = {Bicuspid Aortic Valve (BAV) is a common congenital malformation of the human heart that is identified by an abnormally large aortic valve cusp with a prominent raphe in an area of cuspal fusion. It may be hereditary or familial and is present in $1\%–2\%$ of the population. BAV is associated with valve-related problems that cause aortic valve stenosis or –regurgitation. In addition, congenital abnormalities of the aortic wall such as Interrupted Aortic Arch (IAA), Coarctation of the Aorta (COA), aortic dissection, and aortic aneurysm are more frequently present in BAV disease. Most patients with BAV are unaware of its presence and are at risk for valvular dysfunction and complications during their lifetime. Therefore, follow-up, particularly monitoring of the diameter and the shape of aorta, is extremely important to prevent unsuspected complications such as aortic dissection. Present study reviewed data from 74 patients with IAA (n = 41) and COA with hypoplastic aortic arch (COA-HyAA) (n = 33). Ventricular septal defect (VSD) was present in all patients who underwent early one-stage correction. Only 20 patients had a BAV. Patients’ median age was 7 ± 29 days (range, 2 to 150); median weight was 3.3 ± 0.7 kg (range, 1.5 to 6.0), with 21 patients < 3.0 kg. We retrospectively evaluated the association of BAV in early and late contemporary operation outcomes, including reoperation and transcatheter reintervention rates, after one-stage correction for IAA with VSD or for COA-HyAA with VSD from November 1999 to June 2016 from single high-volume center. The early mortality was $1.3\%.$ Median follow-up was 5.7 years (IQR: 10.48; range, 0.02 to 15.9). There was no mortality during the follow-up. All patients had no obvious neurologic impairment in routine examinations at last follow-up. Reinterventions occurred in 36 $(49\%)$ patients. A potential risk factor for reintervention after IAA and COA with VSD repair was BAV (p = 0.019, Chi²(1)=5.457). In addition, multivariable Cox analyses confirm that BAV (HR=0.381, p=.016), and IAA (HR=0.412, p=0.043) were predictors of late reintervention. Particularly neonates with BAV will possibly require reintervention in the future. Regular lifelong cardiac follow-up is recommended.}, cin = {533540-4 ; 936810}, ddc = {610}, cid = {$I:(DE-82)533540-4_20140620$}, typ = {PUB:(DE-HGF)11}, doi = {10.18154/RWTH-2023-05385}, url = {https://publications.rwth-aachen.de/record/958692}, }